| Scrip code | 000000 |
|---|---|
| NSE Symbol | CHANDAN |
| MSEI Symbol | NOTLISTED |
| ISIN | INE0B2N01016 |
| Name of Company | Chandan Healthcare Limited |
| Type of company | SME |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 14-02-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 09-02-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Third quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Health Care Sector |
| Start date and time of board meeting | 14-02-2026 16:00:00 |
| End date and time of board meeting | 14-02-2026 16:30:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Revenue From Operations | ||
| Revenue from operations | 6,500.74 | 20,081.08 | |
| Other income | 76.55 | 245.49 | |
| Total Income | 6,577.29 | 20,326.57 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 317.68 | 1,681.53 |
| (b) | Purchases of stock-in-trade | 2,936.62 | 8,544.39 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | (249.48) | (332.22) |
| (d) | Employee benefit expense | 1,167.56 | 3,130.04 |
| (e) | Finance costs | 128.02 | 407.97 |
| (f) | Depreciation and amortisation expense | 240.40 | 733.30 |
| (g) | Other Expenses | ||
| 1 | Other Expenses | 1,144.17 | 3,043.70 |
| Total other expenses | 1,144.17 | 3,043.70 | |
| Total expenses | 5,684.97 | 17,208.71 | |
| 3 | Profit before exceptional and extraordinary items and tax | 892.32 | 3,117.86 |
| 4 | Exceptional items | (222.87) | (222.87) |
| 5 | Profit before extraordinary items and tax | 669.45 | 2,894.99 |
| 6 | Extraordinary items | 0.00 | 0.00 |
| 7 | Profit before tax | 669.45 | 2,894.99 |
| 8 | Tax Expense | ||
| Current tax | 208.50 | 707.00 | |
| Deferred tax | (42.28) | 34.01 | |
| Total tax expenses | 166.22 | 741.01 | |
| 9 | Net Profit Loss for the period from continuing operations | 503.23 | 2,153.98 |
| 10 | Profit (loss) from discontinuing operations before tax | 0.00 | 0.00 |
| 11 | Tax expense of discontinuing operations | 0.00 | 0.00 |
| 12 | Net profit (loss) from discontinuing operation after tax | 0.00 | 0.00 |
| 13 | Profit (loss) for period before minority interest | 503.23 | 2,153.98 |
| 14 | Share of profit (loss) of associates | 0.00 | 0.00 |
| 15 | Profit (loss) of minority interest | (49.42) | (140.03) |
| 16 | Net profit (Loss) for the period | 453.81 | 2,013.95 |
| 17 | Details of equity share capital | ||
| Paid-up equity share capital | 2,445.21 | 2,445.21 | |
| Face value of equity share capital | 10 | 10 | |
| 18 | Reserves excluding revaluation reserve | ||
| 19 | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 1.86 | 8.24 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 1.86 | 8.24 | |
| 20 | Debt equity ratio | ||
| 21 | Debt service coverage ratio | ||
| 22 | Interest service coverage ratio | ||
| 23 | Disclosure of notes on financial results | ||
| 20 | Debt equity ratio | |
|---|---|---|
| 21 | Debt service coverage ratio | |
| 22 | Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-10-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 31-12-2025 | 31-12-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | |||||||
| Net Segment Asset | |||||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | |||||||
| Net Segment Liabilities | |||||||
| Disclosure of notes on segments | |||||||